UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 144

Sortiert nach

KRAS Alleles: The Devil Is in the Detail

Trends in cancer, 2017-10, Vol.3 (10), p.686-697

Haigis, Kevin M

2017

Volltextzugriff (PDF)

Tissue-specificity in cancer: The rule, not the exception

Science (American Association for the Advancement of Science), 2019-03, Vol.363 (6432), p.1150-1151

2019

Volltextzugriff (PDF)

The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor

Cell, 2012-03, Vol.149 (1), p.146-158

2012

Volltextzugriff (PDF)

The origins and genetic interactions of KRAS mutations are allele- and tissue-specific

Nature communications, 2021-03, Vol.12 (1), p.1808-14, Article 1808

2021

Volltextzugriff (PDF)

Classification of KRAS-Activating Mutations and the Implications for Therapeutic Intervention

Cancer discovery, 2022-04, Vol.12 (4), p.913-923

2022

Volltextzugriff (PDF)

The adaptive immune system is a major driver of selection for tumor suppressor gene inactivation

Science (American Association for the Advancement of Science), 2021-09, Vol.373 (6561), p.1327-1335

2021

Volltextzugriff (PDF)

Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon

Nature genetics, 2008-05, Vol.40 (5), p.600-608

2008

Volltextzugriff (PDF)

Regulating the regulator: post-translational modification of RAS

Nature reviews. Molecular cell biology, 2012-01, Vol.13 (1), p.39

2012

Volltextzugriff (PDF)

All Roads Lead to Rome: YAP/TAZ Activity Influences Efficacy of KRASG12C Inhibitors

Cancer research (Chicago, Ill.), 2023-12, Vol.83 (24), p.4005

2023

Volltextzugriff (PDF)

HDAC6 and SIRT2 regulate the acetylation state and oncogenic activity of mutant K-RAS

Molecular cancer research, 2013-09, Vol.11 (9), p.1072-1077

2013

Volltextzugriff (PDF)

Computational translation of genomic responses from experimental model systems to humans

PLoS computational biology, 2019-01, Vol.15 (1), p.e1006286-e1006286

2019

Volltextzugriff (PDF)

MK2 contributes to tumor progression by promoting M2 macrophage polarization and tumor angiogenesis

Proceedings of the National Academy of Sciences - PNAS, 2018-05, Vol.115 (18), p.E4236-E4244

2018

Volltextzugriff (PDF)

K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif

Proceedings of the National Academy of Sciences - PNAS, 2015-01, Vol.112 (3), p.779-784

2015

Volltextzugriff (PDF)

SIRT4 loss reprograms intestinal nucleotide metabolism to support proliferation following perturbation of homeostasis

Cell reports (Cambridge), 2024-04, Vol.43 (4), p.113975-113975, Article 113975

2024

Volltextzugriff (PDF)

An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background

Nature (London), 2012-11, Vol.491 (7424), p.449-453

2012

Volltextzugriff (PDF)

The colonic epithelium plays an active role in promoting colitis by shaping the tissue cytokine profile

PLoS biology, 2018-03, Vol.16 (3), p.e2002417-e2002417

2018

Volltextzugriff (PDF)

Regulation of RAS oncogenicity by acetylation

Proceedings of the National Academy of Sciences - PNAS, 2012-07, Vol.109 (27), p.10843-10848

2012

Volltextzugriff (PDF)

SIRT4 Inhibits Glutamate Dehydrogenase and Opposes the Effects of Calorie Restriction in Pancreatic β Cells

Cell, 2006-09, Vol.126 (5), p.941-954

2006

Volltextzugriff (PDF)

RasGRP1 opposes proliferative EGFR-SOS1-Ras signals and restricts intestinal epithelial cell growth

Nature cell biology, 2015-06, Vol.17 (6), p.804

2015

Volltextzugriff (PDF)

A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells

Cell reports (Cambridge), 2017-07, Vol.20 (2), p.427-438

2017

Volltextzugriff (PDF)

Specific Mutations in KRAS Codons 12 and 13, and Patient Prognosis in 1075 BRAF Wild-Type Colorectal Cancers

Clinical cancer research, 2012-09, Vol.18 (17), p.4753-4763

2012

Volltextzugriff (PDF)

Inducible and reversible inhibition of miRNA-mediated gene repression in vivo

eLife, 2021-08, Vol.10

2021

Volltextzugriff (PDF)

MAPKAP Kinase-2 Drives Expression of Angiogenic Factors by Tumor-Associated Macrophages in a Model of Inflammation-Induced Colon Cancer

Frontiers in immunology, 2021-02, Vol.11, p.607891-607891

2021

Volltextzugriff (PDF)

A Compendium of Murine (Phospho)Peptides Encompassing Different Isobaric Labeling and Data Acquisition Strategies

Journal of proteome research, 2021-07, Vol.20 (7), p.3678-3688

2021

Volltextzugriff (PDF)

Brother’s Keeper: Wild-Type Mutant K-Ras Dimers Limit Oncogenesis

Cell, 2018-02, Vol.172 (4), p.645-647

2018

Volltextzugriff (PDF)

1 – 25 von 144

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBlood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(126)

Publikationsform

Sprache

Englisch
(144)
Japanisch
(32)

Erscheinungsjahr

n.n

Thema

Science & Technology
(80)
Life Sciences & Biomedicine
(62)
Animals
(59)
Humans
(54)
Mice
(54)
Mutation
(35)
Cell Biology
(32)
Oncology
(27)
Tumors
(21)
Biochemistry & Molecular Biology
(20)
Cancer
(18)
Multidisciplinary Sciences
(18)
Science & Technology - Other Topics
(18)
Signal Transduction
(18)
Colorectal Cancer
(17)
Mice, Inbred C57bl
(17)
Cell Line, Tumor
(16)
Male
(16)
Biological And Medical Sciences
(14)
Proteins
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

KRAS Alleles: The Devil Is in the Detail

Tissue-specificity in cancer: The rule, not the exception

The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor

The origins and genetic interactions of KRAS mutations are allele- and tissue-specific

Classification of KRAS-Activating Mutations and the Implications for Therapeutic Intervention

The adaptive immune system is a major driver of selection for tumor suppressor gene inactivation

Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon

Regulating the regulator: post-translational modification of RAS

All Roads Lead to Rome: YAP/TAZ Activity Influences Efficacy of KRASG12C Inhibitors

HDAC6 and SIRT2 regulate the acetylation state and oncogenic activity of mutant K-RAS

Computational translation of genomic responses from experimental model systems to humans

MK2 contributes to tumor progression by promoting M2 macrophage polarization and tumor angiogenesis

K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif

SIRT4 loss reprograms intestinal nucleotide metabolism to support proliferation following perturbation of homeostasis

An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background

The colonic epithelium plays an active role in promoting colitis by shaping the tissue cytokine profile

Regulation of RAS oncogenicity by acetylation

SIRT4 Inhibits Glutamate Dehydrogenase and Opposes the Effects of Calorie Restriction in Pancreatic β Cells

RasGRP1 opposes proliferative EGFR-SOS1-Ras signals and restricts intestinal epithelial cell growth

A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells

Specific Mutations in KRAS Codons 12 and 13, and Patient Prognosis in 1075 BRAF Wild-Type Colorectal Cancers

Inducible and reversible inhibition of miRNA-mediated gene repression in vivo

MAPKAP Kinase-2 Drives Expression of Angiogenic Factors by Tumor-Associated Macrophages in a Model of Inflammation-Induced Colon Cancer

A Compendium of Murine (Phospho)Peptides Encompassing Different Isobaric Labeling and Data Acquisition Strategies

Brother’s Keeper: Wild-Type Mutant K-Ras Dimers Limit Oncogenesis

Aktive Filter

Suchergebnisse filtern